Objective. Different prevalences of antiphospholipid antibodies (aPL) have been reported in different populations of patients with systemic lupus erythematosus (SLE). Chinese are generally believed to have lower risk of vascular thrombosis. We examined the prevalence of aPL including lupus anticoagulant (LAC), anticardiolipin (aCL) and anti-β 2- glycoprotein I (anti-β 2-GPI) antibodies, the level of thrombotic risk, and the association of aPL with thrombotic and pregnancy outcomes in a Chinese cohort with SLE at the university lupus clinic during the period 1986-2003. Methods. aPL were measured in 272 SLE patients, and medical records were reviewed for vascular thrombosis and pregnancy outcomes. Results. The prevalence of LAC, IgG aCL, and ...
Background: The anti-phospholipid antibody which can occur secondary to SLE have a broad spectrum of...
Objective: Although systemic lupus erythematosus (SLE) is the most common autoimmune disease associa...
Systemic lupus erythematosus (SLE) is characterized by the presence of serum hypergammaglobulinaemia...
Ninety-one consecutive patients with systemic lupus erythematosus (SLE) were studied. Forty-two pati...
Abstract Objective: Antiphospholipid antibodies (APLAs) have high risk of vascularthrombosis with si...
We investigated the overall frequency of anti-phospholipid syndrome (APS) occurrence in Korean patie...
Anti-phospholipid antibodies (APA) like anti-cardiolipin antibodies (ACA) and anti-β2glycoprotien (a...
Antiphospholipid antibodies (aPL): lupus anticoagulant (LA), anticardiolipin antibodies (aCL) and an...
Palomo, I.G.; Vasquez, M.R. y Alarcon, M.L. Department of Clinical Biochemistry and Immunohematolog...
aPL are frequently present in SLE. In a well characterized SLE cohort we aimed at investigating the ...
Objective. Antiphospholipid antibodies (aPL), namely anticardiolipin antibodies (aCL) and lupus anti...
Antiphospholipid antibodies (aPL) have been linked to various clinical manifestations in systemic lu...
OBJECTIVE: To test the prevalences and the clinical associations of anticardiolipin (aCL) and anti-b...
Backgroud. Which factors determine venous thrombotic events in some antiphospholipid syndrome (APS) ...
The objective is to investigate the role of clinically significant antiphospholipid antibodies (aPL)...
Background: The anti-phospholipid antibody which can occur secondary to SLE have a broad spectrum of...
Objective: Although systemic lupus erythematosus (SLE) is the most common autoimmune disease associa...
Systemic lupus erythematosus (SLE) is characterized by the presence of serum hypergammaglobulinaemia...
Ninety-one consecutive patients with systemic lupus erythematosus (SLE) were studied. Forty-two pati...
Abstract Objective: Antiphospholipid antibodies (APLAs) have high risk of vascularthrombosis with si...
We investigated the overall frequency of anti-phospholipid syndrome (APS) occurrence in Korean patie...
Anti-phospholipid antibodies (APA) like anti-cardiolipin antibodies (ACA) and anti-β2glycoprotien (a...
Antiphospholipid antibodies (aPL): lupus anticoagulant (LA), anticardiolipin antibodies (aCL) and an...
Palomo, I.G.; Vasquez, M.R. y Alarcon, M.L. Department of Clinical Biochemistry and Immunohematolog...
aPL are frequently present in SLE. In a well characterized SLE cohort we aimed at investigating the ...
Objective. Antiphospholipid antibodies (aPL), namely anticardiolipin antibodies (aCL) and lupus anti...
Antiphospholipid antibodies (aPL) have been linked to various clinical manifestations in systemic lu...
OBJECTIVE: To test the prevalences and the clinical associations of anticardiolipin (aCL) and anti-b...
Backgroud. Which factors determine venous thrombotic events in some antiphospholipid syndrome (APS) ...
The objective is to investigate the role of clinically significant antiphospholipid antibodies (aPL)...
Background: The anti-phospholipid antibody which can occur secondary to SLE have a broad spectrum of...
Objective: Although systemic lupus erythematosus (SLE) is the most common autoimmune disease associa...
Systemic lupus erythematosus (SLE) is characterized by the presence of serum hypergammaglobulinaemia...